Key statistics
As of last trade AbbVie Inc (1ABBV:MIL) traded at 160.16, -15.71% below its 52-week high of 190.00, set on Oct 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 160.42 |
---|---|
High | 160.42 |
Low | 160.16 |
Bid | 165.28 |
Offer | 166.38 |
Previous close | 162.78 |
Average volume | 35.33 |
---|---|
Shares outstanding | 1.77bn |
Free float | 1.77bn |
P/E (TTM) | 59.91 |
Market cap | 303.47bn USD |
EPS (TTM) | 2.87 USD |
Annual div (ADY) | 5.68 EUR |
---|---|
Annual div yield (ADY) | 3.49% |
Div ex-date | Oct 14 2024 |
Div pay-date | Nov 15 2024 |
Data delayed at least 15 minutes, as of Nov 21 2024 15:24 GMT.
More ▼
Press releases
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- Seaport Therapeutics Names Lauren White as Chief Financial Officer
- NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines